13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 36 holding rows worth $429,472,000.
- Accession
- 0001172661-21-002382
- Filer
- CIK 1281446
- Filed
- 2021-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 36 entries on the cover page, a total value of $429,472,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $429,472,000 with VALUE read as thousands by filing date, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerYehudai Ortav028-20398
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EXELIXIS INC COM | 30161Q104 | Stock | 1,525,000 | $32,239,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 530,670 | $31,601,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 3,375,000 | $29,396,000 | thousands by filing date | |
| BIOATLA INC | 09077B104 | COM | 844,002 | $24,847,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 765,000 | $22,866,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 1,000,000 | $20,940,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 799,999 | $16,128,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 86,667 | $15,997,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 85,000 | $15,418,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 625,000 | $15,156,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 549,545 | $14,904,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 391,429 | $13,990,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 47,500 | $13,442,000 | thousands by filing date | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 750,000 | $12,615,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 745,000 | $12,099,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 269,010 | $11,920,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 700,000 | $10,696,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 1,974,000 | $9,159,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 1,300,000 | $9,113,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 329,086 | $9,070,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 504,691 | $9,064,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 500,000 | $9,000,000 | thousands by filing date | |
| Rafael Holdings Inc Class B | 75062E106 | COM | 285,714 | $8,780,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 1,170,000 | $8,518,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 1,500,000 | $7,635,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 1,980,000 | $7,187,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 900,000 | $7,155,000 | thousands by filing date | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 220,863 | $7,090,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 200,000 | $6,592,000 | thousands by filing date | call |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 480,000 | $5,467,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 98,061 | $2,488,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 93,137 | $2,444,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 121,342 | $2,395,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 249,000 | $2,378,000 | thousands by filing date | |
| Inflarx Nv | N44821101 | COM | 551,918 | $1,429,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 30,336 | $254,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-21-002382 | this filing | 2021-11-15 | acceptance time not in the bulk data set |